Meningiomas are the most common nonmalignant benign (noncancerous) brain tumors in the US. Though they are considered benign, these tumors can pose challenges for patients, especially when they recur. Join this webinar to learn more about recurrent meningiomas and their management.

Presented by:
Gelareh Zadeh, MD, PhD, FRCS(C), FAANS
Dan Family Chair and Professor of Neurosurgery
University of Toronto

Webinar Overview:
• Learn about the incidence of recurrence in meningiomas
• Identify standard and novel treatment strategies for recurrent meningioma
• Discuss the longterm effects of recurrent meningioma on the quality of life
• Understand how to manage symptoms and side effects related to this diagnosis

~Video Contents~
00:00 Introduction
02:42 Incidence and Recurrence in Meningioma
14:18 Meningioma Grades WHO 2021 Grading
22:10 Managing Recurrent Meningioma Treatments & Side Effects
32:18 Advancements in Diagnosis and Predictors of Recurrence in Meningioma
40:53 Clinical Trials
44:47 Symptom Management and Quality of Life
48:51 Q&A

For more information, resources or support, visit the abta.org, call (800) 8862282 or email [email protected].